drugset / Trial / NCT00035425

Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection

NCT00035425

Phase 3 Completed 120 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will treat patients who have fever and neutropenia (after cancer chemotherapy) that is possibly due to a specific bacteria (gram positive bacteria).

Timeline

Start
2001-11
Primary completion
Completion
2002-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Linezolid Other / unclassified 600 mg Intravenous
Subject Vancomycin Other / unclassified 1 g Intravenous

Indications